Navigation Links
Allscripts to Announce Fiscal Second Quarter Results on January 8, 2009

CHICAGO, Dec. 16 /PRNewswire-FirstCall/ -- Allscripts announced today that it will report its financial results for the three and six months ended November 30, 2008 after the stock market closes on Thursday, January 8, 2009. At 4:30 PM Eastern Standard Time on the same day, Allscripts management will host a conference call and webcast to discuss the company's earnings and other information.


The earnings announcement will be distributed via PR Newswire immediately after the market closes on the afternoon of January 8th. The press release also will be available on the company's website at

To listen to the conference call broadcast, participants may log onto It is recommended that participants log onto the website approximately 15 minutes prior to the start of the conference call to download and install any necessary software. The conference call also can be accessed by dialing (800) 374-1376 and requesting the Allscripts earnings call. A Microsoft Windows Media Player web replay will be available three hours after the conclusion of the call for a period of two weeks at or by calling (800) 642-1687, ID # 77297201.

(Minimum requirements to listen to the broadcast are: Microsoft Windows Media Player software, downloadable free from, an Internet connection, and speakers or earphones).

Upcoming Investor Presentations

Allscripts will present at the following investor events during the three months ended February 28, 2009:

    -- January 12th at the JPMorgan Healthcare Conference in San Francisco
    -- February 9-11 (date unassigned) at the UBS Global Healthcare Services
       Conference in New York

The presentations may be accessed live or as archived files at under the "Company" menu (click "Investor Relations").

About Allscripts

Allscripts (Nasdaq: MDRX) uses innovation technology to bring health to healthcare. More than 150,000 physicians, 700 hospitals and nearly 7,000 post-acute and homecare organizations utilize Allscripts to improve the health of their patients and their bottom line. The company's award-winning solutions include electronic health records, electronic prescribing, revenue cycle management, practice management, document management, medication services, hospital care management, emergency department information systems and homecare automation. Allscripts is the brand name of Allscripts-Misys Healthcare Solutions, Inc. To learn more, visit

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry; possible regulation of the Company's software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; our ability to identify and complete acquisitions, manage our growth and integrate acquisitions; the ability to recognize the benefits of the merger with Misys Healthcare Systems, LLC ("MHS"); the integration of MHS with the Company and the possible disruption of current plans and operations as a result thereof; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers; our ability to obtain, use or successfully integrate third-party licensed technology; breach of our security by third parties; and the risk factors detailed from time to time in our reports filed with the Securities and Exchange Commission, including our 2007 Annual Report on Form 10-K available through the Web site maintained by the Securities and Exchange Commission at The Company undertakes no obligation to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

SOURCE Allscripts
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report
2. Allscripts Announces Expiration of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024
3. Edge Health Solutions Selects Allscripts ePrescribe for Mac OS X Medical and Dental Platform
4. Kindred Healthcare, Nations Largest Post-Acute Healthcare Provider, Selects Allscripts Referral Management
5. Allscripts Announces Notice of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024
6. Allscripts Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
7. Allscripts to Announce Second Quarter 2008 Results on August 5th
8. East Jefferson General Hospital Selects Allscripts Electronic Health Record, Offers Free Electronic Prescribing for Affiliated New Orleans-Area Physicians
9. Hoag Memorial Hospital Presbyterian Selects Allscripts for Electronic Health Record Subsidy Program
10. Martin Memorial Health Systems Selects Allscripts for Electronic Health Record and Practice Management
11. HeartCentrix Informatics Solution from Cardiac Science Now Certified with Allscripts Electronic Health Records
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... CloudLIMS today announced that ... Business Awards under the New Products and Services category for its innovative product ... management software that helps labs organize data and track samples with storage ...
(Date:12/1/2015)... New York, NY (PRWEB) , ... December 01, ... ... cause of non-traumatic limb amputations in the United States. Podiatrists are well aware ... (failure to adopt therapeutic behaviors) are often catastrophic contributors to diseases of the ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... their independence is everything. That is why Hollister Incorporated has launched the VaPro ... offer this next product in the VaPro touch free catheter portfolio,” said Michael ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next IT Healthcare, ... a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program ... as a finalist in the category of Digital Solutions for its innovative, industry-leading ...
(Date:12/1/2015)... ... 01, 2015 , ... TCS Healthcare Technologies (TCS), a leading ... arenas, is pleased to announce that VIP Care Services, a Caprock Health Group ... ACUITY Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015  Eyeon Therapeutics has ... dry eye treatments based on a charged hydrophilic ... delivery CDMO.  The product has been shown to ... previously published.  Mark Mitchnick , MD, CEO ... protection to additional polymers in conjunction with a ...
(Date:12/1/2015)... , December 1, 2015 --> ... report "Immunotherapy Drugs Market by Type of Drug (Monoclonal Antibodies, ... Epidemiology, Regulatory and Pipeline Analysis - Global Forecast to 2020", ... to reach USD 73,529.2 Million by 2020 from USD 40,281.6 ... to 2020. Browse 37 ...
(Date:12/1/2015)... HERTFORDSHIRE, England , BANGALORE, India ... 2015  Mylan N.V. (NASDAQ, TASE: MYL) today announced ... upon regulatory approval and for developing country markets funded ... + Lamivudine 300 mg + Efavirenz 400 mg) for ... Clinton Health Access Initiative (CHAI) to develop TLE400. The ...
Breaking Medicine Technology: